Literature DB >> 23752991

Bladder cancer: second-line nab-paclitaxel for advanced urothelial carcinoma.

Sarah Payton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23752991     DOI： 10.1038/nrurol.2013.131

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.

Authors:  Yoo-Joung Ko; Christine M Canil; Som D Mukherjee; Eric Winquist; Christine Elser; Andrea Eisen; M Neil Reaume; Liying Zhang; Srikala S Sridhar
Journal:  Lancet Oncol       Date:  2013-05-22       Impact factor: 41.316
  1 in total
  1 in total

Review 1.  Alternative fuels for cancer cells.

Authors:  Melissa M Keenan; Jen-Tsan Chi
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.